A first-in-class sclerostin inhibitor—romosozumab

doi:10.3969/j.issn.1672-3384.2020.04.002

ZHANG Shan-shan, HE Xiao-rong, JIANG Wen-qing, WU Xue-jun, KUANG Yong-mei, XU Qiao-ling

Clinical Medication Journal ›› 2020, Vol. 18 ›› Issue (4) : 5-8.

PDF(381 KB)

Clinical Medication Journal ›› 2020, Vol. 18 ›› Issue (4) : 5-8. DOI: 10.3969/j.issn.1672-3384.2020.04.002

New Drugs

A first-in-class sclerostin inhibitor—romosozumab

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2020, 18(4): 5-8 https://doi.org/10.3969/j.issn.1672-3384.2020.04.002

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

Funding

RIGHTS & PERMISSIONS

PDF(381 KB)

Accesses

Citation

Detail

Sections

Recommended

Please choose a citation manager

Content to export